Enclosed herewith Form C received from Mr. Paresh Bhanushali, Promoter of the Company for the disposal of Equity Shares from the market as on August 19, 2024.

pdf

Aspira Pathlab & Diagnostics Ltd.

14 Aug 2024

61.75

4.27%

Company Update

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Enclosed herewith copies of Newspaper Publication for Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2024.

pdf

Aspira Pathlab & Diagnostics Ltd.

13 Aug 2024

61.75

4.27%

Company Update

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement Under Regulation 30-Re-Appointment Of Dr. Haseeb Drabu …

BSE India

Re-appointment of Dr. Haseeb Drabu (DIN:00489888) as the Non-Executive & Independent Director of the Company for the period of 5 years subject to the approval of the members in the ensuing 51st Annual General Meeting of the Company

pdf

Aspira Pathlab & Diagnostics Ltd.

13 Aug 2024

61.75

4.27%

Board Meeting

Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Outcome for Unaudited Standalone And Consolidated …

BSE India

The Board of Directors in its meeting held today approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 ,2024

pdf

Aspira Pathlab & Diagnostics Ltd.

03 Aug 2024

61.75

4.27%

Board Meeting

Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Considering Unaudited Standalone & …

BSE India

Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2024 & other business with the permission of Chair.

pdf